Tirzepatide Weight Loss in Boca Raton, FL

With Tirzepatide now on the market, weight loss methods like bariatric surgery or extreme dieting might just have become a thing of the past. What does your weight loss future look like? Fast forward through a video that you’ve probably played in your mind a thousand times. See yourself shedding 20 percent of your body weight. It doesn’t have to be a dream anymore. Tirzepatide really can help you do it this time.

Tirzepatide is an FDA-approved medication that involves just a simple once-weekly injectable to effectively – and dramatically - target weight gain and obesity. By regulating appetite and insulin, substantial weight loss results like those experienced with Tirzepatide have revolutionized the medical weight loss arena.

To learn more about Tirzepatide - or any of the latest weight loss and medical treatment options we offer at Manhattan Integrative Medicine of South Florida - contact us online or call to schedule your consultation with Florida’s top functional medicine physician and metabolic weight loss specialist. Complete the form below or call us at (754) 247-0122 today!

What is Tirzepatide?

Tirzepatide is a GLP-1 receptor agonist and a gastric inhibitory polypeptide (GIP) analog. Designed as an antidiabetic medication for Type 2 Diabetes, it’s been approved for obesity, weight loss and obstructive sleep apnea as well. It is administered via subcutaneous route, or injections under the skin.

Tirzepatide was approved in the U.S. as a diabetes drug in May 2022, and for weight loss in November 2023. Sold in the U.S. under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea, Tirzepatide can also be compounded by local pharmacists at a much lower cost.

Tirzepatide works the same as brand name Tirzepatide weight loss drugs. Without supply chain interruptions at a fraction of the cost you would pay for the brand name drugs containing Tirzepatide, compounded Tirzepatide has one additional advantage: it can be formulated to your doctor’s precise specifications for your individual needs.

What conditions can Tirzepatide be used to treat?

Tirzepatide is effective for treating weight gain and obesity, but it was primarily developed for Type 2 Diabetes. It is safe and effective to treat obese patients, specifically those with a BMI of 30 or higher – or a BMI of 27 or higher for overweight patients with at least one weight-related medical comorbid condition, either diabetes, obstructive sleep apnea or high blood pressure.

Understanding the Benefits of Tirzepatide

Among its many benefits, Tirzepatide is non-invasive, works quickly, and helps you lose weight without requiring weight loss surgery or resorting to extreme diets.

By enhancing insulin sensitivity and reducing insulin resistance, it helps stabilize blood sugar levels, which is especially beneficial for individuals with Type 2 Diabetes or those who are at risk. Some research even suggests it helps with depression and anxiety, especially if you suffer from diabetes.

Tirzepatide may also have potential benefits for people with heart failure and may lower the risk of cardiovascular events.

Also, because it’s so simple and easy to administer – and begins showing results almost immediately - patients are more motivated to stay on course with it. Overall benefits include:

• Leads to significant weight loss
• Better cardiovascular health
• Reduces inflammation
• Potential cardiovascular benefits
• Stimulates insulin secretion
• Increases satiety
• Reduces glucagon production
• Suppresses appetite
• Reduces blood pressure
• Improves cholesterol levels
• Reduces body fat mass
• Improves insulin sensitivity
• Helps with sleep apnea

One final benefit: it can be compounded locally by a pharmacist you trust to your doctor’s precise specifications at a lower cost than brand name Tirzepatide prescriptions.

What to Expect at Your Tirzepatide Session

On your first visit, Dr. Borenstein will discuss your medical history, lifestyle, daily stressors, diet, exercise habits, and current medications. We recommend that you prepare a list of symptoms prior to your first consultation.

A Tirzepatide consultation, when performed in our offices, typically takes around 15 to 30 minutes and can be completed during your lunch break. Your initial consultation may take longer as we will require a complete medical history. Most patients elect to administer their injections at home, but regularly scheduled appointments are necessary to monitor your health and progress. Appointments can be conducted in person or via our telemed options.

At Manhattan Integrative Medicine in Boca Raton, FL, we offer the most up-to-date testing and medical weight loss treatment with Tirzepatide.

FAQs

How long will it take for me to see the results?

Results vary among Dr. Borenstein’s patients. You may see a difference in appetite your very first day after treatment.

How long will my results last?

Most people need to continue taking Tirzepatide to maintain its effects.

How does Tirzepatide Work?

Tirzepatide works in part by delaying your digestive process - providing a longer lasting feeling of fullness after eating. This can help you feel full on less food.

Tirzepatide activates your GLP-1 and GIP hormone receptors. GLP-1 works on hunger centers in the brain to prevent cravings. GLP-1 also stimulates your pancreas to reduce blood sugar levels and slows emptying of the stomach so you feel full longer. Tirzepatide, unlike other GLP-1 weight loss drugs, also utilizes GIP, which takes it to another level, working in your brain to decrease appetite even further. The one-two punch of GLP-1 and GIP helps to:

• Reduce blood sugar levels
• Reduce cravings
• Slow emptying of your stomach
• Decrease appetite
• And more!

Is Tirzepatide safe for me?

If you have specific allergies (e.g., to stainless steel), have hemostatic (bleeding) dysfunction, anemia, cancer, or blood clotting disorders, any injections may be inadvisable, including weight loss medications like Tirzepatide.

Also, if you are pregnant or nursing or taking certain medications, we may need to delay or advise against treatment.

Tirzepatide is contraindicated if you have:

• Personal or family history of medullary thyroid cancer or MEN syndrome
• Personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Active eating disorder
• Active substance abuse or dependency
• Type 1 diabetes
• Bariatric surgery within the past 18 months
• Pancreatitis within the past 6 months, or a history of pancreatitis caused by taking a GLP-1 drug
• Active gallbladder disease

In general, Tirzepatide has an excellent safety profile. Please discuss all of your safety concerns at our first session. We will evaluate if Tirzepatide is the best choice for you after looking at your medical history, your genetic background and any specific risk factors you may have before we begin your treatment.

Are the Injections painful?

Most of our patients experience little to no discomfort, and most end up self-administering the injections at home.

Request your consultation today!

Dr. David Borenstein is a top functional medicine practitioner in Florida who recognizes that each patient requires a treatment regimen tailored to his or her individual health profile and specific symptoms. For over 20 years, Dr. Borenstein has been helping patients with the problems of weight gain and/or obesity with metabolic weight loss strategies. Tirzepatide is one of greatest new tools in his toolkit to help free his patients from the cycle of weight gain and the associated health risks it brings.

Experience the benefits of Tirzepatide and set yourself free today. Compile your symptoms checklist and call Manhattan Integrative Medicine in Boca Raton, FL at (754) 247-0122 or contact us online.

Serving patients in Boca Raton, West Palm Beach, Jupiter, Boynton Beach, Delray Beach, Parkland, Deerfield Beach, Pompano Beach, Coconut Creek, Coral Springs, Fort Lauderdale, Weston, Hollywood, Pembroke Pines, Aventura, Miami and the surrounding Palm Beach, Broward and Dade County, Florida communities.